Followers | 25 |
Posts | 1513 |
Boards Moderated | 0 |
Alias Born | 12/14/2006 |
![](https://investorshub.advfn.com/uicon/89190.png?cb=1587997560)
Wednesday, February 09, 2011 8:12:33 PM
Chairman and CEO Federico Pignatelli stated, "The recent financial transactions considerably improve our balance sheet by eliminating this high-cost debt and restoring a healthy level of capital. In addition to paying off this debt, we believe the newly raised capital, along with existing cash, is adequate to fund our growth initiatives and meet all of our current operating obligations. We also believe that BIOLASE, with its improved financial strength and expected positive operating results in the first quarter, will achieve a sufficient level of net positive equity to apply for an upgrade to its listing from the current NASDAQ Capital Market to the prestigious NASDAQ Global Market."
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the World's leading Dental Laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
For updates and information on laser and Waterlase dentistry, find BIOLASE at http://www.biolase.com, Twitter at http://twitter.com/GoWaterlase, and YouTube at http://www.youtube.com/user/Rossca08.
This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.
For further information, please contact:
Jill Bertotti
Allen & Caron
+1-949-474-4300
Everything I state is just my own opinion so do your own DD.
Buying great stocks is important but buying great stocks at a great price is even more important.
Recent BIOL News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 10:06:32 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/03/2024 09:17:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 10:42:57 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:30:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:05:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:05:18 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/08/2024 11:31:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:14:14 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:05:29 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:39:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:01:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:15:33 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:10:34 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:26 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:03:55 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 01:44:40 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/07/2024 11:11:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 11:04:56 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/31/2024 02:57:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 10:01:33 PM
- BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024 • PR Newswire (US) • 01/29/2024 11:30:00 AM
FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM